Transcranial Direct Current Stimulation Effects in Patients With Chronic Consciousness Disorders
1 other identifier
interventional
10
1 country
1
Brief Summary
Chronic consciousness disorders have high level of impact on public health and its costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedFirst Posted
Study publicly available on registry
November 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedFebruary 3, 2017
February 1, 2017
2.2 years
January 16, 2014
February 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Coma Recovery Scale Revised (CRS-R)
behavioural scale (visual, auditory, motor, verbal, communication, arousal)
Change measures (weeks: -2,0,1,2,4)
Secondary Outcomes (4)
single-pulse transcranial magnetic stimulation (TMS)
Change measures (weeks: -2,0,1,2,4)
functional near infrared spectroscopy (fNIRS)
Change measures (weeks: -2,0,1,2,4)
electroencephalography (EEG)
Change measures (weeks: -2,0,1,2,4)
Circulating Biomarkers
Change measures (weeks: -2,0,1,2,4)
Study Arms (1)
real-tDCS
EXPERIMENTALParticipants will receive tDCS over the primary motor cortex bilaterally (M1). The excitability-enhancing anode electrode (saline-soaked sponge electrode - 16cm2) will be placed over the primary motor cortex, C3 and C4 (10/20 international EEG system). The excitability-diminishing cathode electrode will be placed over the supraorbital area. We will use the following stimulation parameters: intensity of 2 milliampere and for 40 minutes (10 consecutive sessions).
Interventions
Participants will receive tDCS over the primary motor cortex bilaterally (M1). The excitability-enhancing anode electrode (saline-soaked sponge electrode - 16cm2) will be placed over the primary motor cortex, C3 and C4 (10/20 international EEG system). The excitability-diminishing cathode electrode will be placed over the supraorbital area. We will use the following stimulation parameters: intensity of 2 milliampere and for 40 minutes (10 consecutive sessions).
Eligibility Criteria
You may qualify if:
- males and females aged \>18 years old and \<70 years old
- diagnosis of disorders of consciousness classified as MCS according to criteria of American Academy of Neurology1.
- traumatic etiology (\>12 months after the acute injury)
You may not qualify if:
- contraindications to single pulse TMS (TMS will be used to measure cortical excitability) such as metal head implants, history of seizures, metal in the head, implanted brain medical devices.
- contraindications to tDCS such as metal in the head, implanted brain medical devices.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ferrara University Hospital
Ferrara, Italy, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sofia Straudi, MD
Ferrara Rehabilitation Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
January 16, 2014
First Posted
November 11, 2014
Study Start
September 1, 2014
Primary Completion
November 1, 2016
Study Completion
November 1, 2016
Last Updated
February 3, 2017
Record last verified: 2017-02
Data Sharing
- IPD Sharing
- Will not share